08/27/2024 3:36 PM | Macrae Sandy (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/27/2024 3:37 PM | Dubois-Stringfellow Nathalie (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/27/2024 3:37 PM | Duraibabu Prathyusha (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/27/2024 3:38 PM | Pooler Amy (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/27/2024 3:38 PM | Sangamo Therapeutics (Issuer) Willoughby Scott B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2024 5:40 PM | BIOGEN INC. (Filed by) Sangamo Therapeutics (Subject)
| Form SC 13G/A | |
08/15/2024 3:34 PM | Sangamo Therapeutics (Issuer) Willoughby Scott B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
07/24/2024 3:05 PM | Sangamo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/08/2024 3:32 PM | BlackRock Inc. (Filed by) Sangamo Therapeutics (Subject)
| Form SC 13G/A | |
06/13/2024 3:42 PM | Duraibabu Prathyusha (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:10 PM | Sangamo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/29/2024 4:18 PM | Dubois-Stringfellow Nathalie (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 3:57 PM | Duraibabu Prathyusha (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:00 PM | Pooler Amy (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 3:14 PM | Sangamo Therapeutics (Filer)
| Form ARS | |
03/25/2024 4:04 PM | Sangamo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 6:55 AM | Sangamo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 6:47 AM | Sangamo Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/12/2024 6:11 PM | BIOGEN INC. (Filed by) Sangamo Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 11:17 AM | Sangamo Therapeutics (Subject) WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/06/2024 3:35 PM | Sangamo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/24/2024 3:40 PM | Dubois-Stringfellow Nathalie (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 3:41 PM | Duraibabu Prathyusha (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 3:42 PM | Sangamo Therapeutics (Issuer) Willoughby Scott B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 3:42 PM | Pooler Amy (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 3:39 PM | Macrae Sandy (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 11:18 AM | Sangamo Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/19/2024 4:09 PM | Sangamo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/13/2023 6:55 AM | Sangamo Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/28/2023 3:15 PM | Pooler Amy (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/28/2023 3:16 PM | Dubois-Stringfellow Nathalie (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/28/2023 3:17 PM | Duraibabu Prathyusha (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/28/2023 3:18 PM | Fontenot Jason D. (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/28/2023 3:19 PM | Macrae Sandy (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/28/2023 3:19 PM | McClung David Mark (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/28/2023 3:20 PM | Sangamo Therapeutics (Issuer) Willoughby Scott B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/10/2023 2:09 PM | Sangamo Therapeutics (Subject) WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
09/28/2023 4:30 PM | BIOGEN INC. (Reporting) Biogen MA Inc. (Reporting) Sangamo Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |